OUR TEAM

Ed Haug

Chairman

Ed Haug

Chairman

OVERVIEW

Ed Haug is the Chairman of Haug Partners LLP and was a founding member of the firm in 1997. Mr. Haug is a “ranked trial lawyer” by Chambers, a member of the National Association of Distinguished Counsel, and was recently a member of the CAFC advisory council to Chief Judge Prost.

Mr. Haug has extensive experience in bench and jury trials as well as appellate proceedings having appeared before the U.S. Supreme Court, Court of Appeals for the Federal Circuit and the Second and Fourth Circuits. Mr. Haug has also represented clients involved in proceedings before the U.K. High Court, German Federal Supreme Court and the Tokyo High Court.

In addition to Mr. Haug’s activities as the firm’s Chairman and a practicing trial attorney, Mr. Haug recently served as President of the Federal Circuit Bar Association (“FCBA”) and as a member of the Board of Governors. The FCBA is a national bar association representing approximately 2000 lawyers, judges, and academics practicing before the U.S. Court of Appeals for the Federal Circuit, which sits a short walk away from the firm’s Washington DC office. The Federal Circuit hears all appeals of patent cases in the U.S. and offers a forum for common concerns and dialogue between the private bar, corporations, government employees and the Court. Mr. Haug is a frequent lecturer throughout the world regarding all aspects of trial advocacy with a frequent focus on IP matters.

REPRESENTATIVE CASES

  • Takeda Pharm. Co. Ltd. et al. vs. Norwich Pharm., Inc., 2:20-cv-08966 (D.N.J.)
  • Certain Vehicle Control Systems, Vehicles Containing the Same, and Components Thereof, Inv. No. 337-TA-1235 (I.T.C.)
  • Jaguar Land Rover vs. Bentley Motors Limited, et al., 2:18-cv-00320 (E.D.Va.)
  • Torchlight Tech. LLC vs. Daimler AG, et al., 1:22-cv-000751 (D.Del.)
  • Nygaard vs. Federation Internationale de l’Automobile, et al., 6:20-cv-00234 (W.D.Tex.)
  • MHL Custom, Inc. vs. Waydoo USA, Inc., et al., 1:21-cv-00091 (D.Del.)
  • Supernus Pharm., Inc. v. TWi Pharm., Inc., No. 17-2513 (Fed. Cir.)
  • Shire Orphan Therapies LLC et al v. Fresenius Kabi USA, LLC., No. 1:15-cv-01102-GMS
  • Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd., No. 1:17-cv-11008-MLW
  • Supernus Pharm., Inc. v. Actavis Inc., No. 1:13-cv-04740-RMB-JS (D.N.J.)
  • Supernus Pharm., Inc. v. Actavis Inc., No. 16-1619 (Fed. Cir.)
  • Supernus Pharm., Inc. v. TWi Pharm., Inc., No. 1:15-cv-00369-RMB-JS (D.N.J.)
  • Paice v. Porsche Cars North America, Inc. et al., United States International Trade Commission, (Investigation No. 337-TA-998)
  • Shire Development, LLC et al. v. Watson Pharmaceuticals, Inc. et al., No. 14-206, 135 S. Ct. 1174 (2015)
  • The Medicines Company v. Hospira, Inc., Fed. Cir., No. 2014-1469, (petition for rehearing en banc granted 11/13/15)
  • Shire Development, LLC et al. v. Watson Pharmaceuticals, Inc. et al., No. 12-60862, 2013 WL 1912208 (S.D. Fl. May 9, 2013)
  • Tokyo Electron Arizona, LLC v. Discreet Indus. Corp. et al., No. 01-3245 (E.D.N.Y.)
  • Beacon Navigation GmBH v. Porsche Cars North America, Inc. et al., United States International Trade Commission, (Investigation No. 337-TA-814)
    Shire Development, LLC et al. v. Mylan Pharmaceuticals Development, Inc. et al., No. 8:12-cv-1190-T-36AEP, 2015 U.S. Dist. LEXIS 35882 (M.D. Fla. Mar. 23, 2015)
  • Bowman v. Monsanto, No. 11-796 (U.S. Supreme Court), certiorari granted October 5, 2011
  • Duramed Pharms. Inc. (n/k/a Teva Women’s Health) v. Paddock Labs., Inc., No. 09-1905 (S.D.N.Y.)
  • Johnson Matthey Inc. v. Noven Pharmaceuticals, Inc. and Shire U.S. Inc., No. 07-260 (E.D. Tex.)
  • Marchon Eyewear, Inc. and Rothandberg, inc. v. Tura LP and Brodart Co., No. 98-1932 (E.D.N.Y.)
  • Monica Barba et al. v. Shire US Inc. et al., Case No. 1:13-cv-21158-JAL (S.D. Fl.) (filed April 2, 2013) (Florida)
VIEW ALL

PUBLICATIONS

  • Haug, E. Post-Patent Grant Experimentation as Evidence for Nonobviousness under U.S. Patent Law, GRUR International 4 (2013) 328-332.
  • Haug, E. Claim Construction and Phillips — The ‘Ordinary and Customary Meaning’, in How to Prepare & Conduct Markman Hearings 2006 (PLI, Course Handbook Series 2006).
  • Beyond a Reasonable Doubt (2006)
  • Haug, E., Roger W. Parkhurst & William C. Conner, Demonstration of a Direct and Cross-Examination of a Technical Expert Contending for Obviousness, in Patent Litigation 2004 (PLI, Course Handbook Series 2004).
  • Haug, E. Markman and the Use of Demonstrative Exhibits, in How to Prepare & Conduct Markman Hearings, 2001 (PLI, Course Handbook Series 2001).
  • Haug, E. & Steven B. Pokotilow, Opening Statements – Demonstrations and Panel Critique, in Patent Litigation, 1997 (PLI, Course Handbook Series 1997 – Volume One).
  • Haug, E. & Steven B. Pokotilow, Considerations in Crafting An Opening Statement, in Patent Litigation, 1996 (PLI, Course Handbook Series 1996 – Volume One).
  • Haug, E. Discovery and Related Motion Practice, Winning Strategies in Patent Litigation, 1995 (PLI, Course Handbook Series 1995 – Volume One).
VIEW ALL

SPEAKING ENGAGEMENTS

  • “United States Intellectual Property Developments”, Co-Speaker, Keio IP Forum, March 28, 2023
  • “Latest Developments in U.S. Patent Litigation and PTAB Practice”, Co-Speaker, Keio IP Forum, March 28, 2023.
  • “Risk Management after COVID-19″, Panelist, Directors & Boards Virtual Governance Summit 2020, Webinar, June 5, 2020
  • “Innovation: Key Elements and Challenges”, Moderator, Federal Circuit Bar Association Global Series 2018, Ottawa, Canada, October 10, 2018
  • “Claim Construction and Doctrine of Equivalents – a Comparison Between Germany, Japan and U.S.A.” Boehmert & Boehmert IP Seminar, July 6, 2018
  • “The Global Series Roundtable”, Panelist, Federal Circuit Bar Association Bench & Bar Global Series 2018, Washington, DC, April 19, 2018
  • “Roundtable Discussion”, Co-Moderator, Tokyo University of Science Ogino Lab IP Forum 2018: Patent Developments in Japan, U.S.A. and Europe, Tokyo, Japan, March 14, 2018
  • “Navigating the Unknown: Navigating the storm of uncertain times to ensure sustainability and viability from the biotech angle”, Moderator, BioNJ’s CEO Summit, October 27, 2017
  • “The Series’ Most Challenging Globally: Developing Jurisprudence”, Panelist, Federal Circuit Bar Association Global Series Event, London, UK, September 26, 2017
  • “America Invents Act (AIA): The Effect on Patent Infringement Litigation”, Boehmert & Boehmert IP Seminar, July 5, 2017
  • “Intellectual Property Adjunction-The View from the Bench”, Federal Circuit Bar Association Global Series Event, Paris, France, October 13, 2016
  • “Claim Construction and Doctrine of Equivalents – a Comparison Between Germany, Japan and U.S.A.” Boehmert & Boehmert IP Seminar, July 7, 2016
  • “America Invents Act (AIA): The Effect on Patent Infringement Litigation”, Boehmert & Boehmert IP Seminar, July 6, 2016
  • “The En Banc Panel – Intellectual Property Adjudication and Trade Development”, Moderator, Federal Circuit Bar Association International Series: Shanghai, October 19, 2015
  • “Claim Construction and Doctrine of Equivalents – a Comparison Between Germany, Japan and U.S.A.” Boehmert & Boehmert IP Seminar, July 2, 2015
  • “America Invents Act (AIA): The Effect on Patent Infringement Litigation”, Boehmert & Boehmert IP Seminar, July 1, 2015
  • “The En-Banc Panel – The Courts: The Role of the Judge”, Federal Circuit Bar Association International Series 2014: Geneva – Systems, Challenges, Solutions: Trade, Intellectual Property, Courts, and Governance, Geneva, Switzerland, October 20-21, 2014
  • “Intellectual Property from the Trenches”, Trans-Pacific Health Sciences Dialogue Conference, Philadelphia, PA, September 3, 2014
  • “Patent Enforcement Strategy”, High Technology Protection Summit, University of Washington, CASRIP, July 2014
  • “America Invents Act (AIA): The Effect on Patent Infringement Litigation”, Boehmert & Boehmert IP Training Seminar, Vier Jahreszeiten, Munich, Germany, July 2, 2014
  • “Show Me the Data! Threshold Patent Application Disclosure Requirements and Post-Filing Evidence Admissibility in the U.S., Europe, Canada, and China”, 2014 BIO International Conference, San Diego, CA, June 2014
  • “Global IP Challenge and Trends Impacting the Automotive Industry”, LES International Conference, Moscow, May 19, 2014
  • “Key Developments in Patent Litigation in Japan, U.S., Europe/Germany”, Tokyo University of Science, Tokyo, Japan, April 2014
  • “Case Management in Patent Litigation Under Local Patent Rules”, 2014 Advanced Complex Litigation Series, Patent Litigation in New York Courts: A View From the Bench, NYU Law School, March 2014
  • “Recent IP Related Legislation”, 2013 International Series: Korea-US IP Judicial Conference, October 2013
  • “America Invents Act (AIA): The Effect on Patent Infringement Litigation”, Boehmert & Washington International Series, Washington DC, May 2013.
  • Advanced Complex Litigation, Seton Hall Law School, May 2013
  • CASRIP, Seattle, WA, July 2012
  • “America Invents Act: The Effect of the AIA on Patent Infringement Litigation,” Boehmert & Boehmert IP Training Seminar. Vier Jahreszeiten, Munich, Germany, July 2-7, 2012
  • “Written Description, Utility Model, Validity, and Proof of Infringement in IP Adjudication,” US-China Intellectual Property Adjudication Conference, Renmin University, Beijing, China, May 28-30, 2012
  • GRUR Conference, Frankfurt
  • GRUR Conference at European Patent Office, December 2012
  • ACI Hatch-Waxman Conference, Program Chair
  • “Intellectual Property,” U.S.-Japan Business Council Annual Meeting. Tokyo, Japan, October 6, 2008
  • “Procedural Differences in Europe and the US,” IQPC’s 4th Annual Conference on Polymorphism, Frankfurt, Germany, May 28, 2008
  • Intellectual Property Seminar, Qingdao, China, April 24-25, 2008
  • Bear Stearns Annual Health Care Convention, London, England, March 11, 2008
  • Pharmaceutical Services, Ramsey, New Jersey, September 19, 2007
  • “The Impact of IP on Corporate Transactions,” Law Seminars International’s Conference, Dec. 6, 2006
VIEW ALL

AWARDS

  • Chambers USA
  • Who’s Who Legal, 2022 – Present
  • Lawdragon 500 Leading Lawyers in America, 2020
  • America’s Top 100 High Stakes Litigators®
  • Patent Star by Managing Intellectual Property (MIP) IP Stars, 2020
  • New York SuperLawyers® Metro Edition, 2006- Present
  • Av Preeminent® Rating by Martindale Hubbell
  • The National Association of Distinguished Counsel – Nation’s Top One Percent
VIEW ALL

EDUCATION

  • University of Notre Dame, (B.S., Chem. Eng., 1974), Ford Merit Scholar
  • St. John’s University, (J.D., 1978)
  • Studied at University of Exeter, England
VIEW ALL

BAR ADMISSIONS

  • New York
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Supreme Court
  • Registered to practice before the U.S. Patent and Trademark Office
VIEW ALL

MEMBERSHIPS

  • Lawyers of Distinction
  • Federal Circuit Bar Association, Past-President
  • American Bar Association
  • New York Intellectual Property Law Association
  • International Patent and Trademark Association
  • Member of New Jersey Advisory Patent Rules Committee
VIEW ALL

LANGUAGES

  • German

RELATED SERVICES

Appellate Litigation

Automotive Litigation

Biotechnology Litigation

Class Action Litigation

Commercial Litigation

Consumer Products Litigation

Due Diligence & Investigations

Hatch-Waxman Litigation

Intellectual Property Litigation

ITC Litigation

Licensing & Transactions

Life Sciences Litigation

PTAB Post-Issuance Proceedings

Trade Secret Litigation

VIEW ALL
Haug Partners

CONTACT

LOCATION

New York City
745 Fifth Avenue, 10th Floor, New York, NY 10151
+1.212.588.0800
745 Fifth Avenue, 10th Floor, New York, NY 10151
VIEW IN MAPS
Haug Partners

Locations

New York, NY

745 Fifth Avenue
10th Floor
New York, NY 10151

+1.212.588.0800

West Palm Beach, FL

777 South Flagler Drive
Phillips Point East Tower, Suite 1000
West Palm Beach, FL 33401

+1.561.489.4600

Contact

Follow us

Linkedin Twitter
©2021 Haug Partners
Haug Partners